60 Degrees Pharmaceuticals, Inc. (SXTPW) community

SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value

$0.03−0.00 (-0.38%)

Close on Oct 30, 2026Market cap $3.31MP/E –Yield –

Community

Notes and questions about 60 Degrees Pharmaceuticals from other investors

No posts about SXTPW yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in 60 Degrees Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Jan 20, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SXTPW.

Compare: SXTPW vs DARE · SXTPW vs TRAW · SXTPW vs GOVX · SXTPW vs RFL · SXTPW vs MNOV

Revenue growth73.2% · median -52.3%

Operating margin-774.9% · median -1287.4%

Net margin-729.9% · median -1168.2%

Company	Revenue	Growth
DARE	$1.37M	–
SXTPW	$1.11M	+73.2%
MNOV	$920.48K	–
RFL	$874.00K	-4.7%
TRAW	–	–
GOVX	$0	-100.0%

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 3
Auditor: RBSM LLP
SEC CIK: 1946563

Advertisement
300 × 250